Moreover, miR-101 rich in sEVs inhibited the phosphatase PTEN and activated Akt by targeting membrane-associated guanylate kinase (MAGI-2), resulting in tamoxifen resistance to BC cells (117). The gene discussed is AKT1; the disease is breast cancer.